Close Menu
NEW YORK – The Chan Zuckerberg Initiative and Biohub said on Tuesday they are working with the University of California, San Francisco and Stanford University to increase the Bay Area's novel coronavirus testing capacity by investing in molecular diagnostic platforms from GenMark Diagnostics.
 
The organizations have formed a so-called COVID-19 task force to invest in two GenMark ePlex sample-to-answer molecular diagnostic platforms, one for a CLIA lab at the UCSF Helen Diller Medical Center in Parnassus Heights and one for a CLIA lab at UCSF's Primary Care clinic in C

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.